Sandra Bell
Analyst · Community Capital. Please proceed with your question
Thank you, Michael. On page 4, we highlight the company's key metrics for the second quarter and year-to-date 2018. Net income for the second quarter was $0.9million, an increase of $6.2 million from the prior period. The increase was primarily driven by improvement in income at our specialty insurance subsidiary, and lower corporate expenses. Net income for the year-to-date period was $29.9 million, up significantly from 2017 primarily driven by our gain on the sale of Care in addition to the positive factors impacting the quarter. Within the year-to-date financial, we have taken $11.5 million of unrealized losses primarily from mark-to-market on our Invesque share. Operating EBITDA for the quarter was $15.1 million, up modestly while operating EBITDA for the year-to-date period was $24 million, down 10% from the year earlier period. While both periods were positively impacted by growth in our insurance operations, in the year-to-date period positive performance was more than offset by lower distributions from the sale of our credit related investments. On the bottom of the page, we show a walk from operating EBITDA to pre-tax income highlighting the key drivers of the differences between the two metrics. Book value per share increased to $10.74, up $0.87 from the prior year as the gain on sale of Care, improvement in insurance results, and share buyback overcame any negative factors. Turning to page 5, we highlight our capital allocation and respective return to assist investors in valuing Tiptree. We have detailed our capital between specialty insurance and Tiptree Capital. When considering capital allocation decisions, we look at total capital which includes corporate debt. We evaluate our return on capital using trailing 12 months operating EBITDA which for the most recent period was $58.2 million. Our total return of approximately 8.9% down from the prior year was driven by stronger insurance performance and lower corporate cost, offset by the loss of distributions from credit investment. These returns were slightly lower than we would expect as just over $60 million of excess liquidity has not yet been invested. Before turning to more detail on our businesses, I want to spend just a moment on the impact of the recent corporate structure changes. On April 10th, we completed a reorganization that eliminates Tiptree's dual class structure. This did not impact our book value per share or operating EBITDA metric as we have historically presented those figures on an as exchanged or total company basis. The biggest change which is visible this quarter is a simplified balance sheet and equity statement, providing a simpler financial picture of our company for investors. Now let's turn to our specialty insurance results. On page 7, we highlight our insurance underwriting performance and then on the following page returns from the insurance investment portfolio. We continue to see positive top-line growth across our product line. For the first half of 2018, gross written premiums grew $42.3 million year-over-year, up 12%. Retention of written premium was stable at 52%. As we continue to expand product offerings, we expect that retention rate may expand slightly over time. Of our net written premium, 21% was warranty and other specialty program consistent with the prior year. Underwriting margin grew $7.1 million leading to growth and operating EBITDA of $4.8 million, both driven by strong performance and our credit protection lines. The 19% year-over-year growth in unearned premium reserves and deferred revenue on our balance sheet is consistent with past quarters, and continues to demonstrate future revenue potential. Our combined ratio for the quarter was 93.1 %, a modest improvement from this time last year and continues to demonstrate our ability to profitably grow our insurance business. Turning to the insurance investment portfolio. Our net investments grew by almost $64 million, up 18.4% driven by our growth in net written premium. Net investment income was $9.1 million, up 11% driven by growth in the portfolio and rising interest income on our floating rate asset. Approximately 25% of the $410 million portfolio is floating rate tied to LIBOR. So as rates increased we should expect to see increased yields on that portion of the portfolio. Net portfolio income was $4.7 million for the year-to-date period, up approximately $5 million driven by the same positive factors that drove net investment income plus higher realized gains and lower unrealized losses in interest expense. On page 10, we present the results of Tiptree Capital which consists today of asset management operations, mortgage operations and our ownership of Invesque shares. Over time, we would expect that our investments could shift as we recognize returns in one asset class or business and reinvest in others. Our senior living results now discontinued operations are presented here to facilitate period over period comparison. As a June 30, 2018, our investment Invesque represents $125 million of which $103 million is held in Tiptree Capital. The remainder is in our insurance portfolio. The Invesque shares are subject to transfer restrictions that extend through the middle of 2019, given those restrictions under GAAP as of the end of the second quarter, our valuation represents an approximate $10 million discount to the value of Invesque shares most of which will accrete into our income statement over the remaining period. For the year-to-date period, the dividend income and any fair value unrealized gains or losses on the shares is included another investment. Asset management and credit investment operating EBITDA year-to-date was $1.5 million, down $5.2 million over 2017, driven by the reduced earnings on credited investments mentioned earlier. Mortgage operations were impacted by lower volumes and margins as mortgage interest rates have risen substantially over the past 12 months, providing near-term headwinds for this business. Now we will turn the call back to Michael to conclude our prepared remarks.